Fundz

Cristcot reported raising $10.5 Million in an initial SEC Form D filing, from an offering of $55 Million

PRIVATEJun 06, 2025$10.5M of $55M raised

Amount Raised

$10.5 Million

$10.5 Million sold, per SEC Form D (first sale Apr 25, 2025)

Round Type

Venture

ConcordHealthcareHealth Care

Quick answer

Cristcot raised $10.5 Million in a funding round, dated April 25, 2025. Cristcot is based in Concord, Massachusetts, United States.

How much did Cristcot raise?
Cristcot raised $10.5 Million in a funding round on April 25, 2025.
What does Cristcot do?
Cristcot is a strategic pharmaceutical company focused in the space of gastroenterology to address large gaps in disease management that are overlooked by others and marked by a low competitive landscape.
Where is Cristcot based and how big is it?
Cristcot is based in Concord, Massachusetts, United States. Fundz records about 12 employees.
Who are the decision-makers at Cristcot?
Fundz holds 1 contact at Cristcot. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as Cristcot that raised within 45 days of this round, from Fundz verified event records.

  • TuHURA Biosciences raised $13M (Private Equity) on June 3, 2025.
  • SpyGlass Pharma, Inc. raised $75M (Series D) on June 2, 2025.
  • SpyGlass Pharma, Inc. raised $75M on May 30, 2025.
  • Livmor raised $1M (Seed) on May 29, 2025.
  • Reprieve Cardiovascular raised $31M on May 28, 2025.
  • Dermatologists of Central States raised $622K on May 28, 2025.

Who to call at Cristcot, and when

A new round usually means Cristcot is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cristcot raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cristcot, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cristcot. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cristcot

Location

9 DAMONMILL SQUARE

Concord, Massachusetts, United States

About

Cristcot is a strategic pharmaceutical company focused in the space of gastroenterology to address large gaps in disease management that are overlooked by others and marked by a low competitive landscape. The first product is designed to halt acute flares in ulcerative colitis and has successfully completed Phase 3 clinical trials.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cristcot raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts20 people are listed at Cristcot. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cristcot's next move

See what Strategic adds

Cristcot raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.